Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed as the "DeepSeek moment" for China's drug industry, as biotech emerges as a ...
China’s DeepSeek shocked the world by delivering unexpected innovation at an unbelievable price. But this disruptive trend isn’t confined to Big Tech: it has been quietly happening in the ...
School of Pharmacy, Fudan University, Pudong, Shanghai, China. Over the past decade, research advances, infrastructure and ecosystem improvements and drug regulatory system reforms have boosted the ...
Innorna Co., a Chinese developer of messenger RNA drugs backed by buyout firm CDH Investments, is planning an initial public offering in Hong Kong, according to people familiar with the matter. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback